Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like Zafgen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 12, 2017 COO and First Employee of Editas Medicine to Exit, Effective March 31 March 5, 2017 Takeda Jumps Into the Land of CAR-T R&D With New Tie-Up September 4, 2017
